应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
NVO 诺和诺德
未开盘 01-15 16:00:00 EST
57.12
-1.79
-3.04%
盘后
56.95
-0.17
-0.30%
19:59 EST
最高
57.84
最低
56.29
成交量
2,575万
今开
57.79
昨收
58.91
日振幅
2.63%
总市值
2,536亿
流通市值
1,821亿
总股本
44.39亿
成交额
14.64亿
换手率
0.81%
流通股本
31.88亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
<快讯>英国批准Wegovy 7.2mg三倍剂量！减重超20%，中国会跟进吗？
药见未来 · 10:23
<快讯>英国批准Wegovy 7.2mg三倍剂量！减重超20%，中国会跟进吗？
诺和诺德盘中异动 急速下跌3.03%报57.13美元
市场透视 · 01-15 22:36
诺和诺德盘中异动 急速下跌3.03%报57.13美元
诺和诺德在新任CEO的领导下，致力于多元化的肥胖症治疗Novo Nordisk Targets Diversified Obesity Treatments Under New CEO Leadership
动脉网 · 01-15 17:40
诺和诺德在新任CEO的领导下，致力于多元化的肥胖症治疗Novo Nordisk Targets Diversified Obesity Treatments Under New CEO Leadership
诺和诺德下一代减重新药挺进 III 期
丁香园 Insight 数据库 · 01-15 10:58
诺和诺德下一代减重新药挺进 III 期
200-400亿美元收购，诺和诺德JPM纪要
华创新药 · 01-15 02:03
200-400亿美元收购，诺和诺德JPM纪要
诺和诺德JPM峰会官宣：像卖可乐一样卖减肥药，彻底颠覆传统药企卖药逻辑
GLP1减重宝典 · 01-14 23:13
诺和诺德JPM峰会官宣：像卖可乐一样卖减肥药，彻底颠覆传统药企卖药逻辑
Anthropic与赛诺菲(SNY)、诺和诺德(NVO)等生物制药公司合作进军医疗保健人工智能领域
金吾财讯 · 01-14 17:30
Anthropic与赛诺菲(SNY)、诺和诺德(NVO)等生物制药公司合作进军医疗保健人工智能领域
诺和诺德寻求收购交易强化肥胖症产品组合
界面 · 01-14 13:33
诺和诺德寻求收购交易强化肥胖症产品组合
JPM2026｜诺和诺德：渴求多元化创新，重点关注中国市场
医药魔方 · 01-14 10:24
JPM2026｜诺和诺德：渴求多元化创新，重点关注中国市场
诺和诺德首席执行官表示，2026年该公司在多个市场失去独家经营权可能会导致公司或许迎来艰难的一年
新浪财经 · 01-14 02:19
诺和诺德首席执行官表示，2026年该公司在多个市场失去独家经营权可能会导致公司或许迎来艰难的一年
诺和诺德：口服减肥药将进一步扩大GLP-1药物市场
格隆汇 · 01-13
诺和诺德：口服减肥药将进一步扩大GLP-1药物市场
诺和诺德首席执行官称预计Wegovy将扩大减肥市场。
格隆汇 · 01-13
诺和诺德首席执行官称预计Wegovy将扩大减肥市场。
异动解读 | 诺和诺德盘中大涨5.01%，亚马逊药房上线其减重口服药Wegovy
异动解读 · 01-09
异动解读 | 诺和诺德盘中大涨5.01%，亚马逊药房上线其减重口服药Wegovy
诺和诺德续涨逾4%！亚马逊药房上线其减重口服药Wegovy
老虎资讯综合 · 01-09
诺和诺德续涨逾4%！亚马逊药房上线其减重口服药Wegovy
诺和诺德盘中异动 股价大涨3.84%
市场透视 · 01-09
诺和诺德盘中异动 股价大涨3.84%
美股异动 | 诺和诺德(NVO.US)盘前涨超3.6% 亚马逊药房上线其减重口服药Wegovy
智通财经 · 01-09
美股异动 | 诺和诺德(NVO.US)盘前涨超3.6% 亚马逊药房上线其减重口服药Wegovy
千亿美元“专利悬崖”逼近！美股制药巨头瞄准收购新药，中小盘生物科技股迎来“超级溢价”投资盛宴？
智通财经 · 01-09
千亿美元“专利悬崖”逼近！美股制药巨头瞄准收购新药，中小盘生物科技股迎来“超级溢价”投资盛宴？
“减肥神药”停药后如何？两年内恢复原“胖”
华尔街见闻 · 01-09
“减肥神药”停药后如何？两年内恢复原“胖”
别再只当“避险港”！美股医疗板块撕下防御标签，2026年投资就看这三大风口
智通财经 · 01-08
别再只当“避险港”！美股医疗板块撕下防御标签，2026年投资就看这三大风口
美股异动丨减肥药概念股上涨，礼来涨超5%创新高
格隆汇 · 01-07
美股异动丨减肥药概念股上涨，礼来涨超5%创新高
加载更多
公司概况
公司名称：
诺和诺德
所属市场：
NYSE
上市日期：
--
主营业务：
Novo Nordisk A/S成立于1989年，由两家丹麦公司Nordisk Gentofte A/S和Novo Industri A/S合并而成。该公司是一家全球医疗保健公司，也是糖尿病和肥胖症护理领域的全球领导者。该公司拥有广泛的糖尿病和肥胖症护理以及罕见疾病产品组合，包括用于治疗糖尿病和肥胖症的胰高血糖素样肽-1(GLP-1)受体激动剂、现代胰岛素和人胰岛素。
发行价格：
--
{"stockData":{"symbol":"NVO","market":"US","secType":"STK","nameCN":"诺和诺德","latestPrice":57.12,"timestamp":1768510800000,"preClose":58.91,"halted":0,"volume":25752328,"hourTrading":{"tag":"盘后","latestPrice":56.9501,"preClose":57.12,"latestTime":"19:59 EST","volume":289016,"amount":16501351.402,"timestamp":1768525180721,"change":-0.1699,"changeRate":-0.002974,"amplitude":0},"delay":0,"changeRate":-0.030385333559667275,"floatShares":3187922885,"shares":4439052849,"eps":3.665526,"marketStatus":"未开盘","change":-1.79,"latestTime":"01-15 16:00:00 EST","open":57.79,"high":57.84,"low":56.29,"amount":1464214894.932272,"amplitude":0.026311,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":3.665526,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1768554000000},"marketStatusCode":0,"adr":1,"adrRate":1,"listingDate":363499200000,"exchange":"NYSE","adjPreClose":58.91,"dividendRate":0.030017,"preHourTrading":{"tag":"盘前","latestPrice":57.81,"preClose":58.91,"latestTime":"09:29 EST","volume":618992,"amount":35856154.60152,"timestamp":1768487399999,"change":-1.1,"changeRate":-0.018673,"amplitude":0.022407},"postHourTrading":{"tag":"盘后","latestPrice":56.9501,"preClose":57.12,"latestTime":"19:59 EST","volume":289016,"amount":16501351.402,"timestamp":1768525180721,"change":-0.1699,"changeRate":-0.002974,"amplitude":0},"volumeRatio":1.2988052133783128,"optionData":{"bulkOrders":[{"symbol":"NVO","call":false,"expireDate":1771563600000,"strike":"50.0","timestamp":1768490101662,"price":0.78,"volume":20308,"amount":1584024,"type":"-"},{"symbol":"NVO","call":false,"expireDate":1771563600000,"strike":"55.0","timestamp":1768490101662,"price":2.34,"volume":10154,"amount":2376036,"type":"-"}]},"impliedVol":0.5221,"impliedVolPercentile":0.656},"requestUrl":"/m/hq/s/NVO","defaultTab":"news","newsList":[{"id":"2603953274","title":"<快讯>英国批准Wegovy 7.2mg三倍剂量！减重超20%，中国会跟进吗？","url":"https://stock-news.laohu8.com/highlight/detail?id=2603953274","media":"药见未来","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603953274?lang=zh_cn&edition=full","pubTime":"2026-01-16 10:23","pubTimestamp":1768530206,"startTime":"0","endTime":"0","summary":"英国MHRA重磅批准Wegovy 7.2mg“超高剂量”版本英国药品和保健品监管局刚刚批准了诺和诺德旗下重磅减肥药Wegovy的最新规格——7.2mg注射液。Wegovy 7.2mg在英国的获批释放了一个明确信号：高剂量单药是应对耐药性和追求更高减重目标的下一代解决方案。目前Wegovy已在中国获批上市，但面对国内激烈的GLP-1“百团大战”以及即将到来的替尔泊肽竞争压力，诺和诺德极有可能会加速高剂量版本在全球主要市场的申报进程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116103356a720e1ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116103356a720e1ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","BK4007","IE00BKVL7J92.USD","LU0154236417.USD","LU1093756325.SGD","BK4588","LU1093756168.USD","NVO","BK4585","IE00BZ1G4Q59.USD","BK4532"],"gpt_icon":1},{"id":"2603098698","title":"诺和诺德盘中异动 急速下跌3.03%报57.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603098698","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603098698?lang=zh_cn&edition=full","pubTime":"2026-01-15 22:36","pubTimestamp":1768487785,"startTime":"0","endTime":"0","summary":"北京时间2026年01月15日22时36分，诺和诺德股票出现异动，股价快速下挫3.03%。截至发稿，该股报57.13美元/股，成交量251.782万股，换手率0.06%，振幅1.19%。诺和诺德股票所在的制药行业中，整体跌幅为1.10%。诺和诺德公司简介：诺和诺德在全球品牌糖尿病治疗市场中占据大约三分之一的份额，是世界上领先的糖尿病护理产品供应商。诺和诺德还拥有一个生物制药部门，专注于治疗血友病和其他疾病的蛋白质疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115223625953cf2f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115223625953cf2f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4532","IE00BZ1G4Q59.USD","BK4599","LU0154236417.USD","NVO","BK4588","LU1093756168.USD","LU1093756325.SGD","IE00BKVL7J92.USD","BK4585"],"gpt_icon":1},{"id":"2603073603","title":"诺和诺德在新任CEO的领导下，致力于多元化的肥胖症治疗Novo Nordisk Targets Diversified Obesity Treatments Under New CEO Leadership","url":"https://stock-news.laohu8.com/highlight/detail?id=2603073603","media":"动脉网","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603073603?lang=zh_cn&edition=full","pubTime":"2026-01-15 17:40","pubTimestamp":1768470000,"startTime":"0","endTime":"0","summary":"诺和诺德的这一决定是在该领域对创新解决方案的需求不断增加之际做出的，公司寻求利用其专业知识和资源，针对肥胖症护理的不同方面进行布局。This move signals a significant shift in direction for Novo Nordisk as it adapts to evolving market dynamics under new executive leadership..这一举措表明，在新任高管的领导下，诺和诺德正在适应不断变化的市场动态，实现了方向上的重大转变。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115174330a4c71735&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115174330a4c71735&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4532","IE00BKVL7J92.USD","BK4599","LU1093756168.USD","BK4007","LU1093756325.SGD","BK4585","BK4588","IE00BZ1G4Q59.USD","NVO","LU0154236417.USD"],"gpt_icon":1},{"id":"2603200716","title":"诺和诺德下一代减重新药挺进 III 期","url":"https://stock-news.laohu8.com/highlight/detail?id=2603200716","media":"丁香园 Insight 数据库","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603200716?lang=zh_cn&edition=full","pubTime":"2026-01-15 10:58","pubTimestamp":1768445904,"startTime":"0","endTime":"0","summary":"当地时间 1 月 14 日，诺和诺德在 ClinicalTrials 官网登记了一项NNC0487-0111皮下注射每周一次治疗肥胖人群的III 期临床。公开资料显示，这是该药启动的首个 III 期。受试者将被随机分配接受 NNC0487-0111 或安慰剂，均以皮下注射的方式给药，每周一次。NNC0487-0111是诺和诺德开发的一种单分子、长效的 GLP-1 和胰淀素受体激动剂，有皮下注射制剂和口服制剂。在 2025 年 ADA 大会上，诺和诺德报告了皮下注射NNC0487-0111 针对超重或肥胖人群 的 Ib/IIa 期临床数据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115122918a71cd8a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115122918a71cd8a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1093756168.USD","LU0154236417.USD","BK4007","NVO","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","BK4134","BK4599","BK4532","BK4585","BK4588","LU1093756325.SGD"],"gpt_icon":1},{"id":"2603646143","title":"200-400亿美元收购，诺和诺德JPM纪要","url":"https://stock-news.laohu8.com/highlight/detail?id=2603646143","media":"华创新药","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603646143?lang=zh_cn&edition=full","pubTime":"2026-01-15 02:03","pubTimestamp":1768413828,"startTime":"0","endTime":"0","summary":"我非常荣幸地欢迎诺和诺德的新任首席执行官迈克·杜斯塔达。诺和诺德有 103 年的历史。对于诺和诺德而言，我们认识到当我们专注时，我们会做得非常出色。因此，专注将再次回归到肥胖症和糖尿病。但我们将服务于大约 20 亿患有糖尿病、肥胖症或超重的患者。然后是也许人们有点疑惑的诺和诺德的近期行动。对诺和诺德来说很艰难，对我们的股东来说也很艰难。所以，听到 5500 万人有保险时，确实很令人兴奋。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115020816a71b28fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115020816a71b28fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2264538146.SGD","LU1280957306.USD","LU0820561818.USD","LU0234572021.USD","LU1551013342.USD","LU0683600562.USD","LU0496365809.HKD","BK4599","LU0267386448.USD","LU0154236417.USD","LU0149725797.USD","LU2746668974.SGD","LU0942090050.USD","LU0170899867.USD","LU0964807845.USD","LU0868494617.USD","LU2242649171.HKD","LU2430703095.HKD","LU2236285917.USD","IE00BBT3K403.USD","LU1244550221.USD","LU1496350502.SGD","LU0251132253.USD","LU1119994496.HKD","LU2237443465.HKD","IE00BLSP4239.USD","IE00B775SV38.USD","IE00BFXG1179.USD","LU0238689110.USD","LU0820562030.AUD","IE00BJTD4V19.USD","IE00BN8TJ469.HKD","LU0323591593.USD","LU1974910355.USD","LU2237443382.USD","LU0345770993.USD","LU1551013425.SGD","LU2592432038.USD","LU1116320901.HKD","LU0868494708.USD","BK4585","LU0943347566.SGD","LU1366192091.USD","LU2023250330.USD","IE00BDCRKT87.USD","LU2357305700.SGD","LU0265550946.USD","LU0320765489.SGD","LU1244550577.SGD","LU1267930490.SGD","IE00BYXW3230.USD","LU0265550359.USD","LU0070302665.USD","SG9999002232.USD","IE00BHPRN162.USD","IE00BDRTCR15.USD","LU0417517546.SGD","LU1917777945.USD","LU1629891620.HKD","LU2552382132.HKD","LU1084165304.USD","LU2756315664.SGD","IE0034235295.USD","LU0106261372.USD","LU0256863811.USD","LU2505996509.AUD","LU2054465674.USD","LU2237443622.USD","LU2237443549.SGD","LU2417539215.USD","LU0215105999.USD","LU2756315318.SGD","SG9999002224.SGD","LU2456880835.USD","LU1261432733.SGD","LU0787776722.HKD","LU1988902786.USD","LU1032466523.USD","IE000M9KFDE8.USD","LU1720051017.SGD","LU1720051108.HKD","LU1548497426.USD","LU2552382058.USD","LU1894683348.USD","LU0971096721.USD","LU2462157665.USD","LU0345769128.USD","LU0211326755.USD","BK4566","LU0006306889.USD","NVO","LU0820561909.HKD","LU1244550494.USD","LU0320765646.SGD","LU1064131342.USD","LU2746668461.USD","LU0203347892.USD","IE00BKVL7J92.USD","LU2430703178.SGD","LU2237443895.HKD","IE00BLSP4452.SGD","LU0882574139.USD","BK4533","LU0345769631.USD","IE00BKDWB100.SGD","BK4504","LU0345770308.USD","IE0034235188.USD","LU0211328371.USD","IE0034235303.USD","IE00BWXC8680.SGD","BK4588","LU1363072403.SGD","LU1894683264.USD","IE00B3S45H60.SGD","LU0203345920.USD","LU0640476718.USD","LU1093756325.SGD","LU1670627923.USD","LU2211815571.USD","LU2106854487.HKD","LU2023250504.SGD","BK4534","LU2381873111.SGD","LU1116320737.USD","BK4516","LU2430703251.USD","LU0211326839.USD","BK4550","LU0208291251.USD","IE00BZ1G4Q59.USD","IE00BJLML261.HKD","LU2552382215.SGD","LU1162221912.USD","LU1145028129.USD","LU0211327993.USD","LU0048584097.USD","BK4007","BK4581","LU2023250843.SGD","LU1496350171.SGD","LU2237443978.SGD","LU2213496289.HKD","LU2505996681.GBP","BK4207","IE00B1BXHZ80.USD","LU1914381329.SGD","LU0310799852.SGD","LU1668664300.SGD","LU1670628061.USD","BK4532","IE00BJTD4N35.SGD","LU0106831901.USD","LU0689472784.USD","LU0976567544.SGD","LU1093756168.USD","LU0211331839.USD","IE00B1XK9C88.USD"],"gpt_icon":1},{"id":"2603610661","title":"诺和诺德JPM峰会官宣：像卖可乐一样卖减肥药，彻底颠覆传统药企卖药逻辑","url":"https://stock-news.laohu8.com/highlight/detail?id=2603610661","media":"GLP1减重宝典","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603610661?lang=zh_cn&edition=full","pubTime":"2026-01-14 23:13","pubTimestamp":1768403599,"startTime":"0","endTime":"0","summary":"诺和诺德决定绕开长期受限的保险体系，直接面向患者建立销售通路。底层逻辑在于，诺和诺德希望重新定义减重药的市场属性。Wegovy 的成功，并没有让诺和诺德止步于单一产品。为了补齐速度与多样性，诺和诺德在 JPM 期间安排了超过两百场商务会谈，目标并不局限于单一候选药物，而是覆盖从早期平台到后期资产的多种可能。▍不只是减重，一场更大的代谢赌注尽管肥胖仍是诺和诺德的商业核心，但公司并未将全部筹码押在单一适应症上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011423220997a1d3f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011423220997a1d3f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0820562030.AUD","IE00BBT3K403.USD","LU0170899867.USD","LU0820561909.HKD","LU1244550221.USD","LU2756315318.SGD","LU0942090050.USD","LU2381873111.SGD","SG9999014559.SGD","LU0251132253.USD","BK4007","BK4177","LU0323591593.USD","LU1116320737.USD","LU0048584097.USD","IE0034235188.USD","IE00B3S45H60.SGD","LU1162221912.USD","LU0211328371.USD","LU0211326755.USD","BK4534","LU2125154935.USD","SG9999004303.SGD","LU0154236417.USD","IE00BZ1G4Q59.USD","LU0868494708.USD","LU1551013342.USD","LU0256863811.USD","BK4207","LU2506952097.USD","IE00BLSP4452.SGD","LU2211815571.USD","SG9999003800.SGD","IE00BN8TJ469.HKD","LU0345770308.USD","LU2213496289.HKD","LU2506951875.HKD","LU1720051108.HKD","LU1670711040.USD","IE00BVYPNW00.USD","LU0417517546.SGD","BK4550","LU0738911758.USD","LU2357305700.SGD","LU2360032135.SGD","LU0225283273.USD","LU2054465674.USD","LU2125154778.USD","IE00B775SV38.USD","BK4610","LU0006306889.USD","LU0175139822.USD","LU0795875086.SGD","LU2097829019.USD","LU2552382215.SGD","LU0070302665.USD","LU2505996509.AUD","LU0061474960.USD","LU2417539215.USD","LU0106261372.USD","LU0912757837.SGD","LU1974910355.USD","IE000M9KFDE8.USD","LU0215105999.USD","LU1917777945.USD","LU0106831901.USD","LU1032955483.USD","SG9999015341.SGD","LU0208291251.USD","LU1868837136.USD","LU2237443549.SGD","LU1668664300.SGD","LU1815333072.USD","LU0203345920.USD","IE00B3PB1722.GBP","LU2430703095.HKD","LU2023250504.SGD","LU1003077747.HKD","LU0345769631.USD","LU0683600562.USD","LU2236285917.USD","LU0640476718.USD","LU2456880835.USD","SG9999014542.SGD","LU0265550946.USD","IE00BDGV0183.EUR","LU2106854487.HKD","LU2430703251.USD","LU0950375773.USD","IE00B42XCP33.USD","LU1145028129.USD","LU1496350171.SGD","BK4585","LU0345769128.USD","LU2133065610.SGD","LU1064131342.USD","LU2756315664.SGD","BK4516","LU2505996681.GBP","LU0661504455.SGD","LU1670711123.USD","LU2592432038.USD","LU0943347566.SGD","LU0795875169.SGD","LU2237957811.SGD","SG9999002224.SGD","LU1894683264.USD","BK4581","LU0787776722.HKD","LU0868494617.USD","LU0211326839.USD","IE00BKDWB100.SGD","LU1059921491.USD","LU0820561818.USD","IE00BFXG1179.USD","LU2746668974.SGD","BK4599","LU0976567544.SGD","LU1914381329.SGD","LU2237957902.USD","LU1196500208.SGD","SG9999014575.USD","LU1732799900.SGD","IE00BJTD4N35.SGD","LU1363072403.SGD","LU2108987350.USD","LU0553294199.USD","LU1732800096.USD","BK4559","LU2242649171.HKD","IE0034235295.USD","IE00BDRTCR15.USD","BK4588","LU1868836914.USD","SG9999002232.USD","LU2279689827.SGD","LU0267386448.USD","LU0265550359.USD","LU0289960550.SGD","LU1244550577.SGD","LU1629891620.HKD","LU2746668461.USD","IE00BYXW3230.USD","IE00BWXC8680.SGD","LU1093756325.SGD","BK4504","LU1720051017.SGD","LU1119994496.HKD","LU0203347892.USD","LU1868836757.USD","BK4532","LU1032466523.USD","LU1244550494.USD","LU1670628061.USD","IE00BJLML261.HKD","LU0957791311.USD","LU0949170772.SGD","LU2023250330.USD","LU0545039389.USD","LU1084165304.USD","LU1496350502.SGD","IE00BHPRN162.USD","LU1670710661.SGD","IE00BLSP4239.USD","LU0823417653.USD","LU0096364046.USD","LU1670710588.SGD","IE00BJTD4V19.USD","LU2506952170.USD","IE0034235303.USD","IE00BVYPNV92.GBP","LU1868837300.USD","LU0689472784.USD","LU2552382058.USD","LU0320765646.SGD","LU0345770993.USD","LU0211331839.USD","LU1221951129.SGD","IE00B1XK9C88.USD","LU1670627923.USD","BK4533","IE00BKVL7J92.USD","LU1280957306.USD","LU2552382132.HKD","LU2237443382.USD","LU1116320901.HKD","LU0310799852.SGD","LU1894683348.USD","LU2430703178.SGD","LU2237443895.HKD","LU1093756168.USD","LU2237443465.HKD","LU2462157665.USD","LU0496365809.HKD","LU0098860793.USD","IE00BDCRKT87.USD","LU2264538146.SGD","NVO","LU0882574139.USD","LU0823417737.USD","LU1221951046.USD","LU1551013425.SGD","LU1267930490.SGD","LU0320765489.SGD","LU1988902786.USD","LU2347655156.SGD","LU0061475181.USD","IE00B1BXHZ80.USD","LU2237443622.USD","SG9999011175.SGD","SGXZ23171101.USD","SG9999014567.USD","LU0971096721.USD","LU0234572021.USD","LU1548497426.USD","LU1868836591.USD","IE00BGHQF631.EUR","LU0964807845.USD","LU1261432733.SGD","LU1366192091.USD","LU1718418525.SGD","SG9999015358.SGD","LU2237443978.SGD","LU0149725797.USD","LU2023250843.SGD","LU2506951958.HKD","LU0211327993.USD","BK4566","LU0238689110.USD"],"gpt_icon":1},{"id":"2603569197","title":"Anthropic与赛诺菲(SNY)、诺和诺德(NVO)等生物制药公司合作进军医疗保健人工智能领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2603569197","media":"金吾财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603569197?lang=zh_cn&edition=full","pubTime":"2026-01-14 17:30","pubTimestamp":1768383001,"startTime":"0","endTime":"0","summary":"金吾财讯 | 人工智能初创公司Anthropic与赛诺菲和诺和诺德等生物制药公司合作，推出符合HIPAA法案（Health Insurance Portability and Accountability Act）标准的“Claude for Healthcare”，该工具可整合病历和可穿戴设备数据，并提供预先授权和临床试验工具。","market":"hk","thumbnail":"https://static.szfiu.com/news/20210810/ZDhjMmEyODE0Mjk1MzY2MjA4.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/ZDhjMmEyODE0Mjk1MzY2MjA4.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"296243","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4588","BK4007","BK4599","LU0154236417.USD","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","NVO","BK4585","LU1093756168.USD","SNY","LU1093756325.SGD","IE00BFXG1179.USD"],"gpt_icon":0},{"id":"2603613296","title":"诺和诺德寻求收购交易强化肥胖症产品组合","url":"https://stock-news.laohu8.com/highlight/detail?id=2603613296","media":"界面","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603613296?lang=zh_cn&edition=full","pubTime":"2026-01-14 13:33","pubTimestamp":1768368824,"startTime":"0","endTime":"0","summary":"诺和诺德CEO杜麦克（Maziar Mike Doustdar）当地时间1月13日表示，公司正寻求收购交易以强化其肥胖症产品组合，“无论规模大小”。杜麦克称：“只要其 与我们自身资产互补，我们就可以实行大规模收购，但前提是它必须物有所值”。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114133344953cb270&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114133344953cb270&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BZ1G4Q59.USD","LU1093756168.USD","NVO","BK4532","BK4599","BK4585","LU0154236417.USD","LU1093756325.SGD","BK4588","BK4007","IE00BKVL7J92.USD"],"gpt_icon":0},{"id":"2603065025","title":"JPM2026｜诺和诺德：渴求多元化创新，重点关注中国市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2603065025","media":"医药魔方","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603065025?lang=zh_cn&edition=full","pubTime":"2026-01-14 10:24","pubTimestamp":1768357486,"startTime":"0","endTime":"0","summary":"在JPM2026大会的200余场洽谈中，诺和诺德正在评估各类生物技术创新项目，以寻找到优质标的。目前，诺和诺德一方面持续强化肥胖症治疗领域的产品布局，另一方面积极探索代谢性疾病相关的其他适应症。Lange透露，诺和诺德深度参与本届摩根大通医疗健康大会上安排的超200场会议，旨在挖掘新的候选药物，甚至收购完整的技术平台。为网罗这些多元化的创新项目，诺和诺德采取开放态度，并不限定创新技术的来源，中国自然是重点关注的市场之一。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114103934a7181172&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114103934a7181172&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CQQQ","CWEB","DRAG","MCHI","BK4007","CHAU","BK4532","IE00BZ1G4Q59.USD","KWEB","LU0154236417.USD","ASHS","BK4585","BK4588","ASHR","NVO","BK4614","LU1093756325.SGD","IE00BKVL7J92.USD","FXI","LU1093756168.USD","BK4599"],"gpt_icon":1},{"id":"2603634775","title":"诺和诺德首席执行官表示，2026年该公司在多个市场失去独家经营权可能会导致公司或许迎来艰难的一年","url":"https://stock-news.laohu8.com/highlight/detail?id=2603634775","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603634775?lang=zh_cn&edition=full","pubTime":"2026-01-14 02:19","pubTimestamp":1768328363,"startTime":"0","endTime":"0","summary":"诺和诺德首席执行官表示，2026年该公司在多个市场失去独家经营权可能会导致公司或许迎来艰难的一年。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114022816a716d3d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114022816a716d3d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1093756168.USD","BK4007","BK4588","LU0154236417.USD","BK4532","LU1093756325.SGD","BK4585","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","BK4599","NVO"],"gpt_icon":0},{"id":"2603579529","title":"诺和诺德：口服减肥药将进一步扩大GLP-1药物市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2603579529","media":"格隆汇","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603579529?lang=zh_cn&edition=full","pubTime":"2026-01-13 09:48","pubTimestamp":1768268932,"startTime":"0","endTime":"0","summary":"格隆汇1月13日｜诺和诺德首席执行官Mike Doustdar表示，减肥针剂Wegovy的口服版本，将令更多患者愿意使用相关药物，有助开拓尚未使用GLP-1药物的庞大患者群，进一步扩大相关市场。他表示，目前诺和诺德与礼来在美国合共仅向约1000万至1500万名患者销售GLP-1药物，但全美肥胖人口估计约1.1亿人，市场潜力庞大。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113105654a713ba1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113105654a713ba1a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4588","BK4532","LU1093756168.USD","LU1093756325.SGD","LU0154236417.USD","NVO","BK4007","BK4590","BK4144","IE00BKVL7J92.USD","BK4599","IE00BZ1G4Q59.USD"],"gpt_icon":0},{"id":"2603836542","title":"诺和诺德首席执行官称预计Wegovy将扩大减肥市场。","url":"https://stock-news.laohu8.com/highlight/detail?id=2603836542","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603836542?lang=zh_cn&edition=full","pubTime":"2026-01-13 00:26","pubTimestamp":1768235213,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU1093756168.USD","IE00BZ1G4Q59.USD","BK4588","BK4585","BK4599","BK4007","LU0154236417.USD","BK4532","IE00BKVL7J92.USD","LU1093756325.SGD","NVO"],"gpt_icon":0},{"id":"1159703947","title":"异动解读 | 诺和诺德盘中大涨5.01%，亚马逊药房上线其减重口服药Wegovy","url":"https://stock-news.laohu8.com/highlight/detail?id=1159703947","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159703947?lang=zh_cn&edition=full","pubTime":"2026-01-09 22:42","pubTimestamp":1767969746,"startTime":"0","endTime":"0","summary":"诺和诺德(NVO)今日盘中大涨5.01%，引起了市场的广泛关注。消息面上，亚马逊药房宣布将开始销售诺和诺德的口服减重药Wegovy，这是目前首个也是唯一一个获得美国FDA批准、用于体重管理的口服GLP-1类药物。此举预计将大幅提升Wegovy的可及性和销量，从而推动诺和诺德的业绩增长。Wegovy作为诺和诺德的重要产品，其口服版本的推出和通过亚马逊药房的销售渠道，将进一步巩固公司在减肥药市场的领先地位。市场人士认为，这一合作将显著扩大Wegovy的市场覆盖范围，并对传统药房和药品分销渠道产生深远影响。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"664644e041d7d1a3c24b84c8bab49d56","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["NVO"],"gpt_icon":0},{"id":"1131945153","title":"诺和诺德续涨逾4%！亚马逊药房上线其减重口服药Wegovy","url":"https://stock-news.laohu8.com/highlight/detail?id=1131945153","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131945153?lang=zh_cn&edition=full","pubTime":"2026-01-09 22:37","pubTimestamp":1767969453,"startTime":"0","endTime":"0","summary":"1月9日，$诺和诺德$续涨逾4%，该股已连续六个交易日上涨；$亚马逊$药房上线其减重口服药Wegovy。亚马逊旗下的数字化药房宣布，已开始通过其平台提供诺和诺德旗下的减重药物Wegovy口服片剂。根据公告，符合条件的商业医疗保险用户，通过亚马逊药房购买Wegovy口服片剂，每月最低自付金额可低至25美元；而没有保险的消费者，则可选择透明的自费方案，月度起价为149美元。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"664644e041d7d1a3c24b84c8bab49d56","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"诺和诺德续涨逾4%！亚马逊药房上线其减重口服药Wegovy","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2125154935.USD","LU0070302665.USD","LU0251132253.USD","HK0000914686.HKD","BK4538","BK4550","LU2063271972.USD","BK4561","LU2168564065.EUR","LU2361044865.SGD","LU2471134879.HKD","BK4612","LU0208291251.USD","LU0203201768.USD","LU1791710582.SGD","LU1633808545.USD","LU2552382215.SGD","BK4503","IE00BYQQ9H92.USD","LU0310799852.SGD","LU0316494557.USD","LU0211328371.USD","IE00B5949003.HKD","BK4596","LU2237957811.SGD","LU0823411888.USD","SG9999015952.SGD","LU0312595415.SGD","LU0056508442.USD","IE00B19Z3B42.SGD","LU0109392836.USD","LU1880398471.USD","LU0466842654.USD","LU2552382132.HKD","LU1261432733.SGD","LU0072462426.USD","IE00B1XK9C88.USD","LU0061475181.USD","LU1551013425.SGD","LU2242649171.HKD","IE000ITXATA3.USD","LU0289960550.SGD","LU1815333072.USD","IE00B7SZLL34.SGD","SG9999000418.SGD","LU1116320901.HKD","LU1674673428.USD","LU2543165471.USD","LU2097829019.USD","LU1791710400.SGD","SG9999014906.USD","LU0130102774.USD","LU0342679015.USD","LU2403377893.USD","IE00BMPRXN33.USD","LU0820561909.HKD","LU0265550359.USD","BK4543","LU0345770308.USD","LU2054465674.USD","LU2065171311.SGD","IE00B7KXQ091.USD","IE00BJLML261.HKD","IE00BN29S564.USD","IE0004445239.USD","LU0353189680.USD","LU1066051498.USD","SGXZ51526630.SGD","LU1868836757.USD","IE00BMPRXQ63.HKD","LU1244550221.USD","LU1720051017.SGD","LU2471134523.USD","IE0002270589.USD","SG9999018865.SGD","IE00BK4W5L77.USD","LU0345769631.USD","IE00BJJMRX11.SGD","IE00B4YYXB79.USD","LU1069344957.HKD","LU2764263203.CNY","LU2750360641.GBP","LU1435385759.SGD","IE00B3S45H60.SGD","LU0820562030.AUD","LU2430703095.HKD","LU2362541273.HKD","LU0823421333.USD","LU1201861249.SGD","BK4122","LU1035775433.USD","IE00B19Z3581.USD","LU0823434740.USD","LU2471134796.USD","LU1119994496.HKD","LU0308772762.SGD","LU1935042488.USD","IE00BWXC8680.SGD","LU1718418525.SGD","IE0034235303.USD","LU2764262908.HKD","IE00BJTD4N35.SGD","LU2271345857.HKD","LU0130103400.USD","LU0965509283.SGD","LU0390134368.USD","LU0943347566.SGD","SGXZ31699556.SGD","LU0310800379.SGD","HK0000914660.USD","IE00BKVL7J92.USD","LU0320765059.SGD","LU2357305700.SGD","LU1066051811.HKD","LU0980610538.SGD","LU2381873111.SGD","LU1548497426.USD","LU2860962120.EUR","LU0215105999.USD","BK4527","LU1153585028.USD","LU1551013342.USD","LU2461242641.AUD","LU0096362180.USD","LU0494093205.USD","GB00BDT5M118.USD","LU0234570918.USD","LU1037948897.HKD","IE000KEQY171.SGD","LU0345768740.USD","BK4581","NVO","LU2360032135.SGD","SGXZ99366536.SGD","BK4599","LU1868836591.USD","LU0786609619.USD","LU0109391861.USD","LU0157215616.USD","IE00BQXX3C00.GBP","LU1280957306.USD","LU2087621335.USD","LU2236285917.USD","SG9999014880.SGD","LU2471134952.CNY","BK4551","LU1935042215.USD","SG9999015945.SGD","LU0210536198.USD","IE0004445015.USD","LU2362540622.SGD","IE0001KFT4U8.USD","LU1267930573.SGD","LU0957791311.USD","LU1093756325.SGD","LU1145028129.USD","BK4220","LU2211817866.USD","LU1934455277.USD","BK4579","LU1868836914.USD","LU2552382058.USD","LU0079474960.USD","LU0289941410.SGD","LU0256863902.USD","LU0029864427.USD","LU2746668461.USD","LU2065171402.SGD","LU2463028550.USD","LU2168564495.EUR","LU2264538146.SGD","LU1244550577.SGD","IE0004091025.USD","LU1935043536.SGD","LU2430703178.SGD","LU2764263039.SGD","LU0985320562.USD","LU1778281490.HKD","LU0210533765.USD","LU2896262040.SGD","LU2746668974.SGD","LU2065170008.USD","LU2505996509.AUD","SGXZ81514606.USD","LU0345770993.USD","LU2087625088.SGD","LU0210528500.USD","BK4532","IE00BQXX3F31.USD","BK4554","LU0302445910.USD","SG9999015978.USD","LU0640476718.USD","LU2023250330.USD","BK4585","LU0048584097.USD","LU2108987350.USD","LU0096364046.USD","LU0417517546.SGD","LU1935043023.USD","LU0149725797.USD","IE00BKPKM429.USD","LU0648000940.SGD","LU1839511570.USD","LU0320765489.SGD","BK4535","IE00BK4W5M84.HKD","LU2065169927.USD","LU0162691827.USD","LU2505996681.GBP","IE00B19Z9505.USD","LU1803068979.SGD","SG9999015986.USD","SGXZ23171101.USD","LU2237957902.USD","LU0175139822.USD","LU0267386448.USD","SG9999018857.SGD","IE00B3SWFQ91.USD","LU0198837287.USD","SG9999002224.SGD","LU0672654240.SGD","LU2326559502.SGD","LU1366192091.USD","IE0003U64NQ7.SGD","LU0861579265.USD","BK4588","LU1046421795.USD","BK4533","LU1852331112.SGD","LU1674673691.USD","IE0009356076.USD","LU0070217475.USD","LU1127390331.HKD","IE0005OL40V9.USD","BK4559","LU0353189763.USD","LU2168564149.EUR","IE00B1BXHZ80.USD","BK4534","IE00BJJMRY28.SGD","LU2250418816.HKD","SG9999014914.USD","LU2211815571.USD","LU0787776722.HKD","SG9999001077.SGD","BK7104","LU1868837300.USD","LU0061474960.USD","LU1232071149.USD","LU1861559042.SGD","LU0072461881.USD","LU1429558221.USD","LU2602419157.SGD","BK4507","IE00B775SV38.USD","LU2417539215.USD","LU2247934214.USD","IE00B5TLWC47.USD","LU2452424414.USD","LU0820561818.USD","LU0097036916.USD","LU1116320737.USD","IE0004086264.USD","LU2420271590.USD","LU1988902786.USD","LU0528227936.USD","LU0456855351.SGD","LU0158827781.USD","LU1720051108.HKD","LU0823421416.USD","LU2023251221.USD","LU0256863811.USD","LU0345774631.USD","LU2362541513.USD","LU1093756168.USD","LU0648001328.SGD","IE00BKDWB100.SGD","IE00BMPRXR70.SGD","LU0689472784.USD","LU2592432038.USD","LU0314104364.USD","LU0234572021.USD","LU2111349929.HKD","LU0154236417.USD","LU1861558580.USD","BK4604","LU1880398554.USD","LU0011850046.USD","LU0788109477.HKD","LU0724617625.USD","LU0965509101.SGD","LU1496350502.SGD","LU1914381329.SGD","LU0238689110.USD","IE00BZ1G4Q59.USD","IE00BFXG0V08.USD","BK4566","IE000YTNTUN2.SGD","LU2487616109.SGD","LU1323610961.USD","LU2028103732.USD","LU1084165304.USD","BK4598","LU0708994859.HKD","LU2092937148.SGD","LU0345774391.USD","BK4007","LU1037948541.HKD","IE00B19Z8X17.USD","LU0323591593.USD","LU2089284900.SGD","LU1235294995.USD","LU0107464264.USD","SG9999017495.SGD","LU1201861165.SGD","LU2360106780.USD","LU0265550946.USD","LU2361044949.HKD","LU0127658192.USD","LU1496350171.SGD","LU1814569148.SGD","LU2092627202.USD","LU0082616367.USD","LU1691799644.USD","LU2462157665.USD","LU0354030438.USD","LU0642271901.SGD","LU0077335932.USD","LU0203202063.USD","IE00BJTD4V19.USD","IE00B775H168.HKD","SG9999002232.USD","LU2756315318.SGD","LU0211327993.USD","LU2317271919.USD","LU0683600562.USD","LU2720916845.USD","LU1267930730.SGD","LU1934455194.USD","LU0882574139.USD","LU1989764664.SGD","LU1934455863.HKD","LU2125154778.USD","LU1861127337.USD","SG9999014898.SGD","BK4548","LU2077746001.SGD","IE000W1ABFV2.USD","LU1883839398.USD","LU1074936037.SGD","LU0276348264.USD","LU0345769128.USD","LU1868837136.USD","LU1366333091.USD","IE00B4JS1V06.HKD","IE0009G5SDU7.USD","LU1823568750.SGD","LU2756315664.SGD","LU2456880835.USD","LU0708995401.HKD","LU1064131342.USD","LU2265009873.SGD","LU0345768153.USD","LU2361045086.USD","LU0061474705.USD","IE00B19Z8W00.USD","LU0823434583.USD","LU1989764748.USD","LU0080751232.USD","LU2168563687.JPY","LU2213496289.HKD","LU2168564222.USD","LU1316542783.SGD","LU2242650005.HKD","LU0170899867.USD","LU1804176565.USD","LU0965509010.AUD","LU0965508806.USD","LU1066051225.USD","LU0158827948.USD","LU2750360997.AUD","LU1629891620.HKD","LU0354030511.USD","LU1935042991.SGD","LU1267930490.SGD","LU1244550494.USD","LU1066053197.SGD","BK4524","BK4592","LU2275660780.HKD","LU2237438978.USD","SG9999004303.SGD","IE00BFSS7M15.SGD","LU0348723411.USD","IE00BQXX3D17.EUR","LU0719512351.SGD","LU2430703251.USD","LU0964807845.USD","LU2089283258.USD","LU2083900584.USD","LU0128525929.USD","LU0053666078.USD","IE00BFSS8Q28.SGD","LU0889565833.HKD"],"gpt_icon":1},{"id":"2602374117","title":"诺和诺德盘中异动 股价大涨3.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602374117","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602374117?lang=zh_cn&edition=full","pubTime":"2026-01-09 22:31","pubTimestamp":1767969103,"startTime":"0","endTime":"0","summary":"北京时间2026年01月09日22时31分，诺和诺德股票出现波动，股价快速拉升3.84%。截至发稿，该股报59.54美元/股，成交量215.955万股，换手率0.05%，振幅0.44%。诺和诺德股票所在的制药行业中，整体涨幅为0.44%。诺和诺德公司简介：诺和诺德在全球品牌糖尿病治疗市场中占据大约三分之一的份额，是世界上领先的糖尿病护理产品供应商。诺和诺德还拥有一个生物制药部门，专注于治疗血友病和其他疾病的蛋白质疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109223143a707c5c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"664644e041d7d1a3c24b84c8bab49d56","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109223143a707c5c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","NVO","IE00BKVL7J92.USD","LU1093756168.USD","BK4532","BK4585","LU1093756325.SGD","IE00BZ1G4Q59.USD","LU0154236417.USD","BK4588","BK4007"],"gpt_icon":0},{"id":"2602745003","title":"美股异动 | 诺和诺德(NVO.US)盘前涨超3.6% 亚马逊药房上线其减重口服药Wegovy","url":"https://stock-news.laohu8.com/highlight/detail?id=2602745003","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602745003?lang=zh_cn&edition=full","pubTime":"2026-01-09 22:22","pubTimestamp":1767968549,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周五，诺和诺德股价盘前走高，截至发稿，该股涨超3.6%，报59.41美元。亚马逊旗下的数字化药房宣布，已开始通过其平台提供诺和诺德旗下的减重药物Wegovy口服片剂。这是目前首个也是唯一一个获得美国FDA批准、用于体重管理的口服GLP-1类药物。根据公告，符合条件的商业医疗保险用户，通过亚马逊药房购买Wegovy口服片剂，每月最低自付金额可低至25美元；而没有保险的消费者，则可选择透明的自费方案，月度起价为149美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"664644e041d7d1a3c24b84c8bab49d56","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1391232.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0823421333.USD","LU1720051108.HKD","BK4566","LU1935042991.SGD","LU2357305700.SGD","LU0823434583.USD","IE00BJTD4V19.USD","LU0965509010.AUD","LU1153585028.USD","LU0820561818.USD","LU0128525929.USD","LU2087621335.USD","LU0011850046.USD","LU0070217475.USD","BK4548","LU0302445910.USD","BK4579","LU2097829019.USD","LU0390134368.USD","SG9999002232.USD","LU1935043023.USD","LU0130103400.USD","LU1116320901.HKD","LU1267930730.SGD","LU0528227936.USD","LU1674673691.USD","LU1066051811.HKD","LU0210528500.USD","BK4561","LU0466842654.USD","LU0820562030.AUD","LU1934455863.HKD","LU2264538146.SGD","LU0823434740.USD","LU0289941410.SGD","BK4524","LU2168564222.USD","LU2362541513.USD","LU1037948541.HKD","LU0310799852.SGD","LU1935042215.USD","LU0077335932.USD","LU0082616367.USD","LU1814569148.SGD","LU0323591593.USD","IE00B5949003.HKD","IE00BJLML261.HKD","LU2265009873.SGD","IE00BQXX3C00.GBP","LU2362540622.SGD","LU2211815571.USD","LU2271345857.HKD","IE0034235303.USD","LU1674673428.USD","LU1804176565.USD","LU1880398554.USD","LU0882574139.USD","LU2720916845.USD","LU2361045086.USD","IE00B19Z8W00.USD","IE00BFXG0V08.USD","LU0965509101.SGD","IE0004445239.USD","LU2750360997.AUD","IE0004086264.USD","LU2430703178.SGD","LU1496350502.SGD","LU1316542783.SGD","LU1883839398.USD","LU2505996509.AUD","IE00BFSS8Q28.SGD","LU0965509283.SGD","LU1868837300.USD","LU2552382215.SGD","LU0096362180.USD","LU0157215616.USD","LU0211328371.USD","LU2213496289.HKD","LU2168563687.JPY","LU1235294995.USD","LU1718418525.SGD","LU2168564149.EUR","BK4604","LU2381873111.SGD","LU0130102774.USD","LU2242649171.HKD","LU0354030438.USD","BK4532","LU1201861249.SGD","LU1791710400.SGD","SG9999002224.SGD","IE00B19Z3B42.SGD","LU0980610538.SGD","LU2168564495.EUR","BK4507","LU2552382058.USD","IE00B5TLWC47.USD","LU2242650005.HKD","IE00BKDWB100.SGD","LU2065169927.USD","IE0004091025.USD","BK4554","LU0061474705.USD","LU1037948897.HKD","BK4550","LU1232071149.USD","IE0001KFT4U8.USD","IE00B4JS1V06.HKD","LU2430703095.HKD","HK0000914686.HKD","IE00BQXX3F31.USD","LU0072462426.USD","LU0683600562.USD","LU0154236417.USD","IE00BMPRXN33.USD","LU0158827781.USD","LU1868836757.USD","IE000W1ABFV2.USD","LU0348723411.USD","LU2362541273.HKD","BK4533","LU0345768740.USD","LU2089283258.USD","IE00BMPRXQ63.HKD","IE0005OL40V9.USD","LU2237957811.SGD","LU0070302665.USD","LU1633808545.USD","LU0109391861.USD","LU0053666078.USD","LU2505996681.GBP","IE00BK4W5M84.HKD","SG9999015986.USD","LU2125154935.USD","LU0127658192.USD","BK4596","LU2430703251.USD","SG9999015978.USD","IE0009G5SDU7.USD","LU2065171311.SGD","LU2236285917.USD","USAW.SI","LU0345768153.USD","LU1861558580.USD","LU2023250330.USD","LU2092937148.SGD","LU1868836591.USD","LU0345769631.USD","LU0289960550.SGD","LU0957791311.USD","IE00BKPKM429.USD","LU0353189680.USD","LU0203202063.USD","LU1267930573.SGD","LU2764263203.CNY","IE0003U64NQ7.SGD","LU1127390331.HKD","LU0943347566.SGD","LU0719512351.SGD","BK4503","LU2471134879.HKD","IE00B1XK9C88.USD","BK4534","IE00B3S45H60.SGD","LU1989764664.SGD","IE00B1BXHZ80.USD","LU1093756168.USD","LU1989764748.USD","IE00BMPRXR70.SGD","LU1934455277.USD","LU2746668974.SGD","LU2471134523.USD","LU0672654240.SGD","LU1119994496.HKD","LU0158827948.USD","LU2108987350.USD","LU2125154778.USD","SG9999000418.SGD","LU0096364046.USD","LU1839511570.USD","LU2602419157.SGD","LU0210533765.USD","LU2326559502.SGD","LU1551013342.USD","LU0320765489.SGD","LU0342679015.USD","SG9999001077.SGD","SG9999014880.SGD","IE000YTNTUN2.SGD","LU2237957902.USD","LU1267930490.SGD","IE000KEQY171.SGD","LU0786609619.USD","LU0964807845.USD","LU1868836914.USD","BK4122","LU1046421795.USD","LU1366192091.USD","LU1868837136.USD","LU0345770993.USD","LU0823411888.USD","LU0215105999.USD","IE000ITXATA3.USD","LU2543165471.USD","LU0080751232.USD","LU2764262908.HKD","LU2487616109.SGD","LU0276348264.USD","SGXZ99366536.SGD","IE0002270589.USD","LU0345774631.USD","LU0985320562.USD","IE0009356076.USD","LU1815333072.USD","LU2023251221.USD","IE00BKVL7J92.USD","LU1093756325.SGD","LU2471134952.CNY","LU1244550221.USD","LU1084165304.USD","LU2168564065.EUR","BK4598","LU0210536198.USD","SG9999018857.SGD","LU1496350171.SGD","LU1823568750.SGD","LU0345770308.USD","BK4559","LU1778281490.HKD","LU0211327993.USD","IE00B19Z8X17.USD","LU0208291251.USD","BK4527","LU2028103732.USD","IE00B3SWFQ91.USD","IE00BJJMRX11.SGD","LU1934455194.USD","LU2077746001.SGD","LU0788109477.HKD","LU2552382132.HKD","LU2756315664.SGD","IE00B19Z9505.USD","BK4220","BK4581","LU0708995401.HKD","SG9999014898.SGD","BK4543","LU2275660780.HKD","LU0456855351.SGD","LU2361044865.SGD","LU0256863811.USD","LU1366333091.USD","LU2250418816.HKD","LU0642271901.SGD","LU1551013425.SGD","LU0345774391.USD","LU0048584097.USD","LU2083900584.USD","BK4535","BK4007","LU0251132253.USD","LU1201861165.SGD","LU1244550577.SGD","LU2461242641.AUD","HK0000914660.USD","LU2420271590.USD","LU0175139822.USD","LU1066053197.SGD","LU0310800379.SGD","LU0823421416.USD","LU0265550946.USD","LU0861579265.USD","LU1852331112.SGD","LU0198837287.USD","LU0787776722.HKD","LU0256863902.USD","LU0162691827.USD","LU1244550494.USD","LU0072461881.USD","LU2089284900.SGD","IE00BN29S564.USD","SGXZ51526630.SGD","IE00B775H168.HKD","LU1280957306.USD","LU2065171402.SGD","LU2463028550.USD","LU1429558221.USD","NVO","LU0203201768.USD","IE00B775SV38.USD","LU2360032135.SGD","LU0354030511.USD","LU2417539215.USD","BK4538","LU0267386448.USD","LU2065170008.USD","LU1880398471.USD","BK4551","LU0724617625.USD","LU2860962120.EUR","LU2746668461.USD","IE00BZ1G4Q59.USD","LU0109392836.USD","IE00B4YYXB79.USD","LU0234570918.USD","LU0417517546.SGD","LU2756315318.SGD","LU2092627202.USD","LU1914381329.SGD","SGXZ81514606.USD","LU1035775433.USD","LU1720051017.SGD","LU2054465674.USD","GB00BDT5M118.USD","IE00B7KXQ091.USD","LU1323610961.USD","LU1803068979.SGD","BK4588","LU1935043536.SGD","LU2063271972.USD","IE00BK4W5L77.USD","LU0889565833.HKD","BK4592","LU1069344957.HKD","LU0308772762.SGD","IE00B19Z3581.USD","LU1861559042.SGD","LU1066051498.USD","LU2403377893.USD","LU2360106780.USD","LU0107464264.USD","LU1066051225.USD","LU1691799644.USD","LU1629891620.HKD","LU1861127337.USD","LU0312595415.SGD","LU2211817866.USD","LU2237438978.USD","BK4612","SG9999004303.SGD","LU2111349929.HKD","LU0170899867.USD","LU1145028129.USD","LU2471134796.USD","LU0234572021.USD","IE00BQXX3D17.EUR","LU0097036916.USD","LU0640476718.USD","LU0079474960.USD","LU0820561909.HKD","LU0029864427.USD","LU2592432038.USD","LU2317271919.USD","LU2456880835.USD","LU1435385759.SGD","LU2462157665.USD","LU0149725797.USD","LU0648000940.SGD","IE00BFSS7M15.SGD","LU0314104364.USD","SGXZ23171101.USD","LU0265550359.USD","SG9999017495.SGD","IE0004445015.USD","BK4599","LU0056508442.USD","LU0353189763.USD","LU1791710582.SGD","IE00BWXC8680.SGD","LU1261432733.SGD","LU0689472784.USD","LU0345769128.USD","LU1988902786.USD","LU0316494557.USD","LU2087625088.SGD","LU0238689110.USD","IE00BJJMRY28.SGD","LU2750360641.GBP","LU1074936037.SGD","LU2764263039.SGD","IE00BYQQ9H92.USD","SG9999014906.USD","SG9999015952.SGD","LU0061475181.USD","IE00BJTD4N35.SGD","SGXZ31699556.SGD","LU1548497426.USD","LU0648001328.SGD","LU1116320737.USD","LU0494093205.USD","BK4585","IE00B7SZLL34.SGD","LU1064131342.USD","SG9999018865.SGD","LU0061474960.USD","LU0965508806.USD","SG9999015945.SGD","LU2247934214.USD","LU0320765059.SGD","LU1935042488.USD","LU0708994859.HKD","LU2361044949.HKD","LU2452424414.USD","LU2896262040.SGD","SG9999014914.USD"],"gpt_icon":1},{"id":"2602006340","title":"千亿美元“专利悬崖”逼近！美股制药巨头瞄准收购新药，中小盘生物科技股迎来“超级溢价”投资盛宴？","url":"https://stock-news.laohu8.com/highlight/detail?id=2602006340","media":"智通财经","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602006340?lang=zh_cn&edition=full","pubTime":"2026-01-09 16:00","pubTimestamp":1767945631,"startTime":"0","endTime":"0","summary":"而多种因素共同促成了生物科技并购的爆发式增长。一些全球最畅销的药物正面临在关键地区失去专利保护的风险，这被业内称为“专利悬崖”。据计算，到2032年，畅销品牌专利保护期的丧失将造成至少1739亿美元的年销售额损失。生物科技板块近几年经历繁荣、衰退，然后又是繁荣新冠疫情期间，生物科技行业迅速成为投资者的热门之选。Loren表示，一系列利好数据也推高了生物科技股的估值。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1390856.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"美股制药巨头瞄准收购新药，中小盘生物科技股迎来“超级溢价”投资盛宴？","news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["PFE","LLY","NVO","AZN","BMY","NVS","GSK","MRK"],"gpt_icon":1},{"id":"2602113923","title":"“减肥神药”停药后如何？两年内恢复原“胖”","url":"https://stock-news.laohu8.com/highlight/detail?id=2602113923","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602113923?lang=zh_cn&edition=full","pubTime":"2026-01-09 08:51","pubTimestamp":1767919888,"startTime":"0","endTime":"0","summary":"最新研究显示，停服Ozempic等抗肥胖药物后，患者体重反弹普遍且迅速，预计两年内恢复原重，心脏健康等获益将在18个月内消失。专家警告，缺乏持续干预难以维持疗效。此外，若无专业指导，自行用药还面临营养不良和肌肉严重流失的风险。","market":"fut","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":{"source":null,"url":"https://wallstreetcn.com/articles/3762907","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3762907","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4157","NVO","BK4132","LLY"],"gpt_icon":0},{"id":"2601410362","title":"别再只当“避险港”！美股医疗板块撕下防御标签，2026年投资就看这三大风口","url":"https://stock-news.laohu8.com/highlight/detail?id=2601410362","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601410362?lang=zh_cn&edition=full","pubTime":"2026-01-08 22:10","pubTimestamp":1767881428,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，长期以来，美国股市中的医疗健康板块一直被视为防御性板块，这得益于行业龙头企业稳定的增长态势与可观的股息收益率。在这一背景下，许多投资专业人士预计，医疗健康板块的上涨势头将延续至2026年。相反，Lang将医疗健康板块视作更具进攻性的投资标的。美国食品药品监督管理局预计将于2026年初，就是否批准礼来的口服肥胖症治疗药物作出决定。它们原本预计，特朗普政府将提高对老年医保私人承办机构的财政补贴。","market":"us","thumbnail":"https://static.tigerbbs.com/b72c7a49848a200043090f96ed32f108","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/b72c7a49848a200043090f96ed32f108"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"e178ff119c0760983ef52ddddb4229df","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1390609.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["UNH","LLY","NVO"],"gpt_icon":1},{"id":"2601235804","title":"美股异动丨减肥药概念股上涨，礼来涨超5%创新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2601235804","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601235804?lang=zh_cn&edition=full","pubTime":"2026-01-07 23:18","pubTimestamp":1767799100,"startTime":"0","endTime":"0","summary":null,"market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"b2662d3ff1dff9c19973bc9c47bc6f94","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IE00B775H168.HKD","LU2023250504.SGD","SG9999015978.USD","IE00BJJMRY28.SGD","LU1064131342.USD","IE0004445239.USD","LU0432979614.USD","LU2237443978.SGD","GB00BDT5M118.USD","LU2462157665.USD","LU1623119135.USD","LU2265009873.SGD","LU2461242641.AUD","LU0466842654.USD","LU1127390331.HKD","LU1323610961.USD","IE00B1BXHZ80.USD","LU2491050154.USD","IE00B1XK9C88.USD","LU0672654240.SGD","LU0640476718.USD","IE00BJJMRZ35.SGD","LU1366192091.USD","IE00BK4W5M84.HKD","LU1868837136.USD","LU0353189680.USD","SG9999018857.SGD","LU0114720955.EUR","LU2552382132.HKD","LU2237443549.SGD","LU2237443622.USD","LU2552382215.SGD","BK4585","LU1093756168.USD","LU0266013472.USD","LU0316494557.USD","LU0786609619.USD","LU1280957306.USD","LU2361044949.HKD","LU0122379950.USD","LU0106261372.USD","IE00BFSS8Q28.SGD","LU2746668974.SGD","SGXZ31699556.SGD","IE00BWXC8680.SGD","LU0079474960.USD","LU1988902786.USD","IE00BKPKM429.USD","LU1267930730.SGD","LU1057294990.SGD","LU2602419157.SGD","LU1917777945.USD","SG9999015952.SGD","IE00BJJMRX11.SGD","LU2168564149.EUR","LU2168564065.EUR","IE0009355771.USD","LU0471298777.SGD","IE0005OL40V9.USD","IE00BK4W5L77.USD","AMGN","IE00BN29S564.USD","LU0820561909.HKD","BK4599","LU0823434740.USD","LU0198837287.USD","LLY","IE0004445015.USD","LU0708995401.HKD","LU2471134879.HKD","LU0354030438.USD","LU0471298694.HKD","LU0323591593.USD","LU0203202063.USD","LU2089984988.USD","LU2237443465.HKD","LU1814569148.SGD","LU2471134796.USD","SG9999013999.USD","LU0353189763.USD","LU2750360641.GBP","RHHBY","LU1069344957.HKD","LU1551013425.SGD","LU1061106388.HKD","LU2361045086.USD","LU1023059063.AUD","IE00BFTCPJ56.SGD","IE00BFSS7M15.SGD","LU2211815571.USD","LU0354030511.USD","LU2237438978.USD","IE00B4R5TH58.HKD","SG9999014914.USD","LU2491049909.HKD","SGXZ51526630.SGD","LU1868836757.USD","LU2112291526.USD","BK4588","LU0823434583.USD","LU2063271972.USD","LU2361044865.SGD","SG9999001176.SGD","SG9999017495.SGD","LU2237443895.HKD","LU0094547139.USD","LU1712237335.SGD","LU0320765992.SGD","SG9999015986.USD","LU0787776722.HKD","LU1720051017.SGD","SGXZ81514606.USD","BK4516","LU1868836914.USD","LU2491050071.SGD","IE00B7KXQ091.USD","LU2746668461.USD","LU1983299246.USD","LU1035775433.USD","LU0689472784.USD","IE0002141913.USD","LU0320765059.SGD","SGXZ99366536.SGD","SGXZ57979304.SGD","LU2456880835.USD","LU0097036916.USD","LU0234572021.USD","BK4581","IE00BJT1NW94.SGD","LU2087625088.SGD","IE00BJLML261.HKD","SG9999015945.SGD","LU0943347566.SGD","LU2552382058.USD","LU1232071149.USD","LU0096364046.USD","LU0256863811.USD","LU1720051108.HKD","LU2108987350.USD","LU0058720904.USD","LU0061475181.USD","LU0683600562.USD","LU2471134952.CNY","LU0385154629.USD","LU0006306889.USD","BK4534","SG9999014906.USD","LU2168564495.EUR","LU2106854487.HKD","LU0109391861.USD","LU2360106947.USD","SG9999014880.SGD","BK4533","LU2417539215.USD","LU0109394709.USD","LU0889565916.HKD","LU1804176565.USD","LU0882574055.USD","LU2236285917.USD","LU1551013342.USD","LU0820561818.USD","LU1093756325.SGD","LU0456855351.SGD","NVO","LU1868837300.USD","LU0882574139.USD","LU0203201768.USD","SG9999014898.SGD","04332","LU1989771016.USD","SG9999001176.USD","LU2324357040.USD","LU2168564222.USD","LU0256863902.USD","LU0289739699.SGD","LU2471134523.USD","BK4007","LU0238689110.USD","LU2750360997.AUD","LU1974910355.USD","LU1548497426.USD","IE00BKDWB100.SGD","LU2168563687.JPY","LU2264538146.SGD","IE00B2B36J28.USD","LU2357305700.SGD","IE00B4JS1V06.HKD","LU0823416689.USD","LU2237443382.USD","LU1868836591.USD","LU0417517546.SGD","SG9999018865.SGD","LU1291159041.SGD","LU2468319806.SGD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.novonordisk.com","stockEarnings":[{"period":"1week","weight":-0.0038},{"period":"1month","weight":0.1667},{"period":"3month","weight":0.0506},{"period":"6month","weight":-0.1118},{"period":"1year","weight":-0.3111},{"period":"ytd","weight":0.1226}],"compareEarnings":[{"period":"1week","weight":0.004},{"period":"1month","weight":0.0197},{"period":"3month","weight":0.0419},{"period":"6month","weight":0.103},{"period":"1year","weight":0.1678},{"period":"ytd","weight":0.0151}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Novo Nordisk A/S成立于1989年，由两家丹麦公司Nordisk Gentofte A/S和Novo Industri A/S合并而成。该公司是一家全球医疗保健公司，也是糖尿病和肥胖症护理领域的全球领导者。该公司拥有广泛的糖尿病和肥胖症护理以及罕见疾病产品组合，包括用于治疗糖尿病和肥胖症的胰高血糖素样肽-1(GLP-1)受体激动剂、现代胰岛素和人胰岛素。","yearOnYearQuotes":[{"month":1,"riseRate":0.533333,"avgChangeRate":0.119096},{"month":2,"riseRate":0.613636,"avgChangeRate":0.028062},{"month":3,"riseRate":0.454545,"avgChangeRate":0.006986},{"month":4,"riseRate":0.613636,"avgChangeRate":0.01505},{"month":5,"riseRate":0.555556,"avgChangeRate":0.018382},{"month":6,"riseRate":0.688889,"avgChangeRate":0.026171},{"month":7,"riseRate":0.488889,"avgChangeRate":-0.001692},{"month":8,"riseRate":0.533333,"avgChangeRate":0.006145},{"month":9,"riseRate":0.555556,"avgChangeRate":-0.002979},{"month":10,"riseRate":0.488889,"avgChangeRate":-0.004606},{"month":11,"riseRate":0.6,"avgChangeRate":0.026574},{"month":12,"riseRate":0.733333,"avgChangeRate":0.048757}],"exchange":"NYSE","name":"诺和诺德","nameEN":"Novo-Nordisk A/S"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"诺和诺德(NVO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供诺和诺德(NVO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"诺和诺德,NVO,诺和诺德股票,诺和诺德股票老虎,诺和诺德股票老虎国际,诺和诺德行情,诺和诺德股票行情,诺和诺德股价,诺和诺德股市,诺和诺德股票价格,诺和诺德股票交易,诺和诺德股票购买,诺和诺德股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"诺和诺德(NVO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供诺和诺德(NVO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}